| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.598 | 39.715 | 27.529 | 57.965 | 55.329 | 55.224 | 85.434 | 97.762 | 70.943 | 76.593 |
| Total Income - EUR | 26.598 | 39.717 | 27.542 | 59.073 | 55.334 | 55.236 | 85.440 | 97.802 | 70.947 | 76.714 |
| Total Expenses - EUR | 24.663 | 36.090 | 34.191 | 59.585 | 48.940 | 52.300 | 68.470 | 94.292 | 69.518 | 71.520 |
| Gross Profit/Loss - EUR | 1.934 | 3.627 | -6.649 | -512 | 6.394 | 2.937 | 16.970 | 3.510 | 1.429 | 5.194 |
| Net Profit/Loss - EUR | 1.136 | 2.436 | -7.246 | -1.103 | 5.841 | 2.400 | 16.316 | 2.679 | 755 | 3.123 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medisante Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.533 | 3.923 | 3.561 | 3.784 | 51.028 | 41.864 | 30.202 | 19.638 | 40.070 | 45.877 |
| Current Assets | 10.114 | 18.376 | 12.189 | 2.761 | 4.712 | 4.665 | 6.048 | 4.557 | 5.942 | 1.886 |
| Inventories | 1.781 | 2.839 | 3.091 | 0 | 0 | 0 | 28 | 0 | 172 | 0 |
| Receivables | 4.370 | 4.538 | 5.117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 3.964 | 10.999 | 3.980 | 2.761 | 4.712 | 4.665 | 6.021 | 4.557 | 5.770 | 1.886 |
| Shareholders Funds | 10.850 | 12.051 | 4.601 | 3.413 | 9.196 | 11.422 | 25.357 | 24.230 | 19.997 | 23.009 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.797 | 10.248 | 4.355 | 3.132 | 46.823 | 35.107 | 11.448 | 800 | 27.906 | 26.676 |
| Income in Advance | 0 | 0 | 6.862 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Medisante Srl